News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chugai Pharmaceutical Co., Ltd. (Japan) And F. Hoffmann-La Roche Ltd. (RHHBY) Release: Overseas Co-Promotion of Actemra(R), a Treatment for Rheumatoid Arthritis


5/8/2007 11:57:55 AM

Tokyo, May 7, 2007 (JCN Newswire) - Chugai Pharmaceutical Co., Ltd. announced today that under the terms of the license agreement signed with F. Hoffmann-La Roche on the humanized anti-human IL-6 receptor monoclonal antibody Actemra, it has decided not to exercise the opt-in right for co-promotion in the United States, Italy and Spain, and will co-promote the product with Roche in France, Germany and the United Kingdom.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES